spond to the residues lining the pockets within the pepPockets in the peptide binding site spaced to accomtide binding site. The allelic differences influence the modate peptide side chains at the P1, P4, P6, and P9 peptide binding specificity of the various class II MHC positions have been previously characterized and help alleles and thus determine allele-specific differences in to explain the obtained peptide binding specificity.
would appear to be due to an interaction between the peptide P10 residue and HLA-DR1. As noted above, a side-chain binding pocket at this position has not been described in HLA-DR1 or any other class II MHC protein, and peptide binding motifs generally do not include a side chain preference at this position. It is possible, however, that these peptides bind in an expected conformation, or that one (or both) of the peptides binds in an unexpected register or conformation; for example, the peptide might "bulge," as observed in complexes of peptides bound to class I MHC proteins [24] , shifting the peptide side chains that are accommodated in the MHC pockets. To elucidate the structural basis for the apparent specificity at the P10 position, we crystallized HLA-DR1 in complex with the AAYSDQATPLLLSPR peptide and determined its structure by X-ray diffraction methods.
Crystal Structure of HLA-DR1 Reveals a P10 Shallow Pocket or Shelf
The X-ray crystal structure of HLA-DR1 bound to the AAYSDQATPLLLSPR peptide was determined in two crystal forms, one with two molecules in the asymmetric unit, and another with one molecule in the asymmetric unit in complex with the bacterial superantigen SEC3-3B2 that has been used previously to facilitate crystallization of HLA-DR variants (Table 1) . SEC3-3B2 makes contacts with the ␣ chain of HLA-DR1 outside the binding site and does not contact the peptide [25, 26] . In each of the structures, clear and continuous density was observed for essentially all of the MHC protein, excluding a disordered loop away from the peptide binding site, and also for all of the bound peptide from the of these structures were identical in the three views of the molecule provided by these crystals, except for some crystal contacts that vary between the crystals forms ( Figure 2B ). We were not able to obtain crystals Results and Discussion of HLA-DR1 in complex with the other peptide (AAYSD QATPLLGSPR).
The P10 Position Can Influence Binding of Peptides to HLA-DR1
The peptide P10 residue and the area surrounding the MHC region were well-resolved in each of the crystal Two peptides with sequences differing only by a single amino acid predicted to occupy the P10 pocket (AAYSD forms, with the exception of the terminal methyl groups of the P10 Leu. HLA-DR1 residues located in close prox-QATPLLLSPR and AAYSDQATPLLGSPR) bind to HLA-DR1 with 15-fold different apparent affinity as measured imity to the P10 side chain are Arg␣76, Pro␤56, Asp␤57, and Tyr␤60 ( Figure 2C ). These residues form a shallow by a competition assay ( Figure 1B) . The peptide sequences derive from the integrin ␤3 peptide previously pocket or "shelf" that accommodates the P10 residue ( Figure 2D by the P10 residue is hydrophobic. The fraction buried assay ( Figure 3A ). The peptide sequence is similar to that used in the structural work described above, except for the residue at P10 is 0.63, which is comparable to the fraction buried for residues in the P3 (0.65), P4 (0.69), that (P7) was changed to the more favorable Leu (P7), eliminating possible backbone conformational and enand P7 (0.77) pockets. Crystal structures are currently available for six other HLA-DR molecules in complex tropic effects unique to proline (I.S., Z.Z.-R., and L.J.S., unpublished data). Peptide binding competition IC 50 valwith peptides that extend to the P10 position. In each of these, the residues that line the P10 pocket are orgaues are shown in Table S1 (see the Supplemental Data) and are plotted in Figure 3B relative to the average of nized essentially identically to the complex reported here ( Figure S2A ; see the Supplemental Data). In each all peptides in the series. Clearly there is peptide side chain specificity at the P10 position, with phenylalanine case, the P10 residue is substantially buried in the pocket (with the exception of DRB5*0101 in complex and tyrosine strongly preferred and asparagine, proline, and serine disfavored. with a peptide from Epstein-Barr virus, where the peptide binds in an unusually extended conformation with the P9 residue contacting the P10 pocket) ( Figure S2B) .
Allelic Polymorphism at the P10 Region of HLA-DR Inspection of the HLA-DR1 structure in the vicinity of Binding Specificity to the P10 "Shelf" on HLA-DR1 In order to explore peptide binding specificity for the the P10 shelf shows that the residues Arg␣76, Pro␤56, Asp␤57, and Tyr␤60 play the major roles in formation P10 side chain, we synthesized a set of peptides that contained the AAYSDQATLLLXSPR sequence, where X of the shelf and interaction with the peptide (Figures 2C  and 2D ). Arg␣76 is part of the nonpolymorphic ␣ subunit, is one of the 20 natural amino acids, and measured their relative affinity for HLA-DR1 in a competition binding and Pro␤56 is conserved within all the HLA-DR alleles, but Asp␤57 and Tyr␤60 are highly polymorphic (Table  S2 ). In the context of other class II MHC proteins, polymorphism at Asp␤57 has been linked to human (HLA-DQ) and murine (I-A g7 ) diabetes [5, 8]. We attempted to evaluate the effect of these polymorphisms on peptide side chain specificity at the P10 position by using published studies. The influence of ␤57 and ␤60 on HLA-DR peptide binding specificity has been studied systematically as part of a pocket-based matrix approach to epitope prediction [17], but the P10 pocket was not included in the analysis. For I-A g7 , a mouse class II MHC protein, it has been suggested that polymorphism at ␤57 can effect side chain preference at both the P9 and P10 positions [27] . Lists of peptides known to bind to particular human MHC alleles, and predicted allele-specific peptide binding motifs, have been collected in several databases, although quantitative data on the MHC-peptide binding interaction are not included [18, 19] . We scanned one such database, SYFPEITHI, for sets of similar HLA-DR1 alleles that differ in the P10 pocket residues ␤57 and ␤60 and for which reliable peptide binding motifs were available. DRB1*0401, DRB1*0404, and DRB1*0405 form such a set. These alleles differ only at positions ␤57 (Asp or Ser), ␤71 (Arg or Lys), and ␤86 (Gly or Val) (Figure 4) . The polymorphism at ␤71 is not expected to significantly influence peptide side chain specificity, as both Arg␤71 and Lys␤71 form a similar hydrogen bond with the peptide main chain carbonyl at position 5, between the P4 and P6 pockets (Table S3 ). While the databases do not contain quantitaSignificance tive binding data on these peptides, it is evident that the alleles have selected sets of peptides that differ in MHC genes are the most polymorphic in the human genome. This polymorphism results in different pepthe residue predicted in the P10 position, with the HLA-DRB1*0405 binding set enriched in charged amino acid tide binding specificities for the corresponding allelic variant proteins. Thus, different individuals will react residues at the expense of hydrophobic and aromatic residues (Figure 4) . Thus, the ␤57 polymorphism apdifferently to a set of peptides from a particular antigen, with implications for vaccine design and susceppears to influence the P10 peptide binding specificity.
tibility to autoimmune and infectious diseases. Algorithms that predict peptide binding to common human HLA-DR1 with Polymorphic Substitutions in the P10 Region Exhibits Altered P10 Specificity allelic variants are available and have found use in the study of autoimmune target antigens, in the design of To evaluate in a more quantitative way the influence of HLA-DR polymorphic residues on P10 specificity, we immunogenic and nonimmunogenic protein therapeutics, and in development of subunit-based vaccines. constructed a series of P10 pocket variants of HLA-DR1 (DRB1*0101) and evaluated their binding to the P10 For HLA-DR proteins, the most prevalent type of human class II MHC protein, such approaches generally peptide libraries as described above. Single and double amino acid replacements of polymorphic residues in account only for specificity at the P1-P9 positions of peptide antigen. Here, we have investigated an interthe P10 shelf (␤D57A, ␤D57A/Y60H, ␤D57V, and ␤D57V/ Y60S) were introduced into HLA-DR1 so that their efaction outside this region, at the P10 position, which contributes significantly to the overall peptide binding fects on P10 binding specificity could be isolated (naturally polymorphic variants at these positions also have affinity. In a crystal structure of HLA-DR1 bound to a To make HLA-DR1-␤D57A, the primers used were 5Ј-GACGGAGC crude peptides were purified by high-performance liquid chroma-TGGGGCGGCCTGCTGCCGAGTATTGGAAC-3Ј (sense) and 5Ј-GTT tography (Vydac-C18). The purity and homogeneity of each peptide CCAATACTCGGCAGCAGGCCGCCCCAGCTCCGT-3Ј (antisense). was checked by high-performance liquid chromatography (VydacFor HLA-DR1-␤D57A/Y60H, the primers used were 5Ј-GAGCTGGGG C18) and MALDI-TOF mass spectrometry. Peptide concentrations CGGCCTGCTGCCGAGCACTGGAACAGCCAGAAGGAC-3Ј (sense) were measured by absorbance at 280 nm (ʦ 280nm ϭ 1280 M Ϫ1 cm Ϫ1 ) and 5Ј-GTCCTTCTGGCTGTTCCAGTGCTCGGCAGCAGGCCGCC in the case of peptides containing tyrosine or weredetermined by CCAGCTC-3Ј (antisense). The primers for HLA-DR1-␤D57V were using amino acid analysis in the case of CLIP peptide.
5Ј-GACGGAGCTGGGGCGGCCTGTGGCCGAGTATTGGAAC-3Ј (sense) and 5Ј-GTTCCAATACTCGGCCACAGGCCGCCCCAGCTCCGTC-3Ј (antisense). For HLA-DR1-␤D57V/Y60S, 5Ј-GAGCTGGGGCGGCCTGTG Protein Expression and Purification
For peptide binding experiments and X-ray crystallography, the ex-GCCGAGTCTTGGAACAGCCAGAAGGAC-3Ј (sense) and 5Ј-GTCCTT CTGGCTGTTCCAAGACTCGGCCACAGGCCGCCCCAGCTC-3Ј (antitracellular portion of HLA-DR1 was produced from S2 (Schneider sense) were used. The HLA-DR1 mutants were expressed in E. coli tor, and minimization. A 2-fold noncrystallographic symmetry (NCS) averaging improved the quality of the electron density map. inclusion bodies and refolded and isolated as described above for wild-type HLA-DR1.
In 
